It's been just a week since MobiHealthNews rounded up personnel moves in digital health, but already a few more companies have announced C-level hires.
Treato, an Israeli company that scours thousands of social media sites to glean patient insights about pharmaceuticals and treatments, has hired Greg Gallo to be the company’s Chief Commercial Officer. Gallo previously worked as Chief Commercial Officer for Activate Networks, which developed an algorithm that analyzes the relationships between people in order to find influential leaders and communities.
Grail, which is developing a blood test that helps in the early diagnosis of cancer in asymptomatic people, has hired Google X Senior Vice President Jeff Huber as its CEO. “Jeff helped Google map the world, and he’ll help us map the molecular biology of the microscopic cancer DNA that might be circulating in our blood,” Jay Flatley, chairman of the board of GRAIL and Illumina CEO said in a statement. Before working at Google, Huber also held positions at eBay, @Home Network, and McKinsey & Company.
Sensoria, a wearable sensor company that has developed sensor-embedded smart socks, has appointed Dr. David G. Armstrong, a podiatric surgeon, to its Scientific Advisory Board. Armstrong will help Sensoria with the scientific validation of the company’s technology for clinical applications. “Dr. Armstrong is renowned for his research in amputation prevention, diabetic foot, wound healing and the merger of consumer electronics with medical devices,” Sensoria CEO Davide Vilano said in a statement. “…We are very excited to have such a qualified expert to spearhead our new advisory board efforts to further Sensoria’s impact in the clinical space.”